Hutano Diagnostics

Nottingham, United Kingdom Founded: 2018 • Age: 8 yrs Acquired By EDX Medical Group
Diagnostic tools for early disease detection and management are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 5 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 7 Brand Intelligence

About Hutano Diagnostics

Hutano Diagnostics is a company based in Nottingham (United Kingdom) founded in 2018 by Atherton Mutombwera was acquired by EDX Medical Group in October 2023. The company has 5 employees as of March 31, 2022. Hutano Diagnostics offers products and services including Sepsis LFD, Paediatric Fever LFD, and Modular LFD Platform. Hutano Diagnostics operates in a competitive market with competitors including MiCoBioMed, Homed-IQ, In Diagnostics, Glowvista Instruments and Lumeox, among others.

  • Headquarter Nottingham, United Kingdom
  • Employees 5 as on 31 Mar, 2022
  • Founders Atherton Mutombwera
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Hutano Diagnostics Ltd
  • Date of Incorporation 20 Mar, 2018
  • Jurisdiction OXFORD, ENGLAND
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    5

    as on Mar 31, 2022

  • Acquired by
    EDX Medical Group

    (Oct 27, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Hutano Diagnostics

Hutano Diagnostics offers a comprehensive portfolio of products and services, including Sepsis LFD, Paediatric Fever LFD, and Modular LFD Platform.

Product name locked
Category locked
Primary

Lateral flow device for detecting sepsis biomarkers in patients.

Product name locked
Category locked
Locked

Test for identifying bacterial versus viral illness in children.

Product name locked
Category locked
Locked

Platform for multiplex biomarker detection in point-of-care settings.

Funding Insights of Hutano Diagnostics

Premium access

Detailed funding history for Hutano Diagnostics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Hutano Diagnostics

Hutano Diagnostics has secured backing from 1 investor. Prominent investors backing the company include EDX Medical Group.

All
Investor Description Founded Year Domain Location
Medical diagnostics solutions are researched by the laboratory.
Locked Locked Locked
Premium access

Investor details for Hutano Diagnostics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Hutano Diagnostics

Investments
Premium access

Investment portfolio details for Hutano Diagnostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Hutano Diagnostics

Premium access

Detailed financials for Hutano Diagnostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hutano Diagnostics Comparisons

Hutano Diagnostics Primary company
Description
Diagnostic tools for early disease detection and management ...
Location
Nottingham, United Kingdom
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
5
As of 2022
Premium access

Peer comparison for Hutano Diagnostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Hutano Diagnostics

Hutano Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiCoBioMed, Homed-IQ, In Diagnostics, Glowvista Instruments and Lumeox, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Glucose monitoring sensors and surface plasmon resonance devices are produced.
Locked Locked Locked
At-home diagnostic test kits are provided for medical health assessments.
Locked Locked Locked
Develops and sells microchip-powered blood testing kits for research and veterinary diagnostics.
Locked Locked Locked
AI-based diagnostic devices for multiple diseases are provided.
Locked Locked Locked
Develops mobile blood analyzers for emergency medical services.
Premium access

Detailed competitors of Hutano Diagnostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hutano Diagnostics

Premium access

Complete news archive for Hutano Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hutano Diagnostics

Hutano Diagnostics was founded in 2018.

Hutano Diagnostics is headquartered in Nottingham, United Kingdom.

Atherton Mutombwera is the current CEO of Hutano Diagnostics. They have also founded this company.

As of Mar 31, 2022, the latest employee count at Hutano Diagnostics is 5.

Hutano Diagnostics was founded in 2018 and is based in Nottingham, United Kingdom. Operations center on the diagnostics sector, where a lateral flow diagnostic platform is developed to distinguish bacterial from viral infections, identify relevant bacteria, and assess sepsis risk using finger-prick samples. This tool supports early prognosis and management of illnesses, with services targeted at healthcare applications.

Hutano Diagnostics's top competitors include MiCoBioMed, Homed-IQ and Glowvista Instruments.

Hutano Diagnostics offers Sepsis LFD, Paediatric Fever LFD, and Modular LFD Platform.

Hutano Diagnostics has 1 investor. Key investors include EDX Medical Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available